New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Datroway becomes the first and only therapy to show overall survival benefit versus chemotherapy in this difficult-to-treat patient population
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Rifaximin tablets are a rifamycin antibacterial indicated for reducing the risk of overt hepatic encephalopathy
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
Deflazacort oral suspension is indicated for treating Duchenne Muscular Dystrophy in patients 5 years of age and older
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Subscribe To Our Newsletter & Stay Updated
